This Month
- Exclusive
- Start-ups
Start-up to sell ‘unapproved’ replica Ozempic, upending market
Eucalyptus is challenging the monopoly over the diabetes and weight-loss drug, sparking a sharp rebuke from the $505 billion drugmaker Novo Nordisk.
- Nick Bonyhady
- Opinion
- Pharmaceuticals
Investors can’t help gorging on anti-obesity drugs
The wall of capital going into this area is great for patients. But not all the treatments will be winners for shareholders.
- Chris Hughes
October
Shortage means Ozempic clients sent elsewhere – at twice the price
High demand is making the diabetic and weight loss drug hard to get, and customers have been offered three options: an alternative for twice the price, a half dosage or drop it altogether.
- Julie Hare
Beware of the Ozempic hype and its irrational market outcomes
ResMed and CSL have been hit hard by the weight-loss drugs wave, but the reality is that no one knows how the GLP-1 drug landscape will play out.
- Kelli Meagher
I walked off 35 kilos and beat my sugar cravings
Ten years ago, my belly was enormous but when I looked in the mirror, I’d pull in my stomach and think I still looked great. It took a health scare to change my ways.
- Ian Walker
Eucalyptus ups capital raising with $8m second close
The raise predates the Medical Board of Australia cracking down on telehealth prescribing via text, taking its latest funding round to almost $60 million.
- Nick Bonyhady
September
- Exclusive
- Start-ups
Ozempic-selling start-up Eucalyptus does ‘silent dismissals’
The company’s boss, Tim Doyle, defended its culture, saying its rapid growth required “structured performance management reviews”.
- Nick Bonyhady
- Opinion
- Alcohol
Weight loss drugs such as Ozempic also cut the desire to drink alcohol
The makers of intoxicating beverages could become big losers if the likes of Wegovy and Mounjaro become widely used.
- Lisa Jarvis and Leticia Miranda
August
WeightWatchers gambles everything on obesity drugs
Ozempic and Wegovy could save the 60-year-old business – if they don’t kill it first.
- Emma Court and Ellen Huet
How Ozempic is upending the weight loss industry
This week in The Fin podcast, technology writer Nick Bonyhady and health editor Jill Margo on how Ozempic has upended the weight-loss industry, the companies trying to make money from it and the health risks threatening to derail its meteoric rise.
July
- Analysis
- Pharmaceuticals
The alarming twist when using Ozempic for weight loss
Ozempic is a model appetite suppressant, improves blood glucose control, reduces insulin resistance and is effective for diabetes, but there are several unknowns.
- Jill Margo
Eucalyptus’ Ozempic pivot walks a fine line
Its Ozempic mailout may be entirely within the law. Still, it does seem to go against the spirit of the thing.
- Myriam Robin
- Exclusive
- Healthcare
Eucalyptus changes tune and begins selling Ozempic
Eucalyptus, which recently bought the longstanding Jenny Craig weight loss brand, has long made a point of not selling the buzzy weight loss drug, but that is changing.
- Nick Bonyhady
June
- Analysis
- Entrepreneur Summit
Ozempic’s ‘an eating disorder’: Kayla Itsines and tech entrepreneur clash
The high-profile fitness instructor hit out at the use of drugs like Ozempic on a Financial Review panel alongside the CEO of weight-loss injection selling start-up Eucalyptus.
- Nick Bonyhady
- Opinion
- AFR Magazine
Thin is in but Ozempic has a big fat problem
When the diabetes drug that aids weight loss arrives in Australia, how does the fashion industry respond? With good old capitalist hustle.
- Lauren Sams
May
Shortage of diabetes-turned-weight loss drug Ozempic to ease
Extra supplies of the diabetes drug, Ozempic, which is highly sought after for weight loss, should arrive in Australia by July, according to the Therapeutics Goods Administration.
- Jill Margo
Weight-loss firm Jenny Craig shuts down, files for US bankruptcy
The move spells the end for the weight-loss program built around ready meals - the company will cease operating and see its assets sold off in pieces.
- Amelia Pollard
March
The real reasons you’re not losing weight
From nodding off in front of the TV to your smartwatch addiction, here are the surprising habits that are sabotaging your diet goals.
- Mary Comber
January
- Opinion
- Life & Leisure
These non-alcoholic drinks are as good as the real thing
When ‘Higher Sobriety’ author Jill Stark gave up alcohol for a year a decade ago, there were few good boozeless options. How times have changed.
- Max Allen
January
This trend to get cheekbones like Bella Hadid could backfire
A facial-slimming treatment that has taken TikTok by storm could have disastrous consequences later in life, because cheekbones can be too high, despite what you may think.
- Annabel Jones
